101 related articles for article (PubMed ID: 25877316)
1. [Analysis of the changes of blood glucose after radiotherapy in pancreatic cancer patients associated with diabetes mellitus and their related factors].
Li Y; Pan M; Qiu S; Wang P; Shao X; Zhang L
Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):33-6. PubMed ID: 25877316
[TBL] [Abstract][Full Text] [Related]
2. Two different types of diabetes mellitus in pancreatic cancer population. Comparative study between new onset and long standing diabetes mellitus on 76 patients with pancreatic cancer.
Tanţău A; Negrean V; Alexescu T; Para I; Tărmure S; Casoinic F; Sâmpelean D; Mocanu T; Tanţău M
Rom J Intern Med; 2014; 52(1):18-23. PubMed ID: 25000673
[TBL] [Abstract][Full Text] [Related]
3. Value of Early Check-Up of Carbohydrate Antigen 19-9 Levels for Pancreatic Cancer Screening in Asymptomatic New-Onset Diabetic Patients.
Choe JW; Kim JS; Kim HJ; Hwang SY; Joo MK; Lee BJ; Kim JH; Yeon JE; Park JJ; Byun KS; Bak YT
Pancreas; 2016; 45(5):730-4. PubMed ID: 26646277
[TBL] [Abstract][Full Text] [Related]
4. Diabetes mellitus in pancreatic cancer follow-up.
Fogar P; Pasquali C; Basso D; Sperti C; Panozzo MP; Tessari G; D'Angeli F; Del Favero G; Plebani M
Anticancer Res; 1994; 14(6B):2827-30. PubMed ID: 7532931
[TBL] [Abstract][Full Text] [Related]
5. Elevated pancreatic polypeptide levels in pancreatic neuroendocrine tumors and diabetes mellitus: causation or association?
Maxwell JE; O'Dorisio TM; Bellizzi AM; Howe JR
Pancreas; 2014 May; 43(4):651-6. PubMed ID: 24713673
[TBL] [Abstract][Full Text] [Related]
6. Serum metabolomics differentiating pancreatic cancer from new-onset diabetes.
He X; Zhong J; Wang S; Zhou Y; Wang L; Zhang Y; Yuan Y
Oncotarget; 2017 Apr; 8(17):29116-29124. PubMed ID: 28418859
[TBL] [Abstract][Full Text] [Related]
7. [Abnormal metabolism of glucose as clue for early diagnosing pancreatic cancer].
Wu J; Meng X; Li D; Lu H
Zhonghua Yi Xue Za Zhi; 2002 Mar; 82(5):312-4. PubMed ID: 11953187
[TBL] [Abstract][Full Text] [Related]
8. [miRNA-192, miRNA-21 and miRNA-200: new pancreatic cancer markers in diabetic patients?].
Škrha P; Hořínek A; Anděl M; Škrha J
Vnitr Lek; 2015 Apr; 61(4):351-4. PubMed ID: 25894267
[TBL] [Abstract][Full Text] [Related]
9. New-onset diabetes patients need pancreatic cancer screening?
Lee JH; Kim SA; Park HY; Lee KH; Lee KT; Lee JK; Bae JC; Kim KW
J Clin Gastroenterol; 2012 Aug; 46(7):e58-61. PubMed ID: 22138846
[TBL] [Abstract][Full Text] [Related]
10. Levels of Alternatively Spliced Tissue Factor in the Plasma of Patients with Pancreatic Cancer May Help Predict Aggressive Tumor Phenotype.
Unruh D; Sagin F; Adam M; Van Dreden P; Woodhams BJ; Hart K; Lindsell CJ; Ahmad SA; Bogdanov VY
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1206-11. PubMed ID: 25963480
[TBL] [Abstract][Full Text] [Related]
11. Serum CA242, CA199, CA125, CEA, and TSGF are Biomarkers for the Efficacy and Prognosis of Cryoablation in Pancreatic Cancer Patients.
Chen Y; Gao SG; Chen JM; Wang GP; Wang ZF; Zhou B; Jin CH; Yang YT; Feng XS
Cell Biochem Biophys; 2015 Apr; 71(3):1287-91. PubMed ID: 25486903
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of diabetes mellitus in pancreatic cancer compared to common cancers.
Aggarwal G; Kamada P; Chari ST
Pancreas; 2013 Mar; 42(2):198-201. PubMed ID: 23000893
[TBL] [Abstract][Full Text] [Related]
13. Temporal association of changes in fasting blood glucose and body mass index with diagnosis of pancreatic cancer.
Pannala R; Leibson CL; Rabe KG; Timmons LJ; Ransom J; de Andrade M; Petersen GM; Chari ST
Am J Gastroenterol; 2009 Sep; 104(9):2318-25. PubMed ID: 19513024
[TBL] [Abstract][Full Text] [Related]
14. Do hyperglycemia and diabetes affect the incidence of false-negative 18F-FDG PET/CT studies in patients evaluated for infection or inflammation and cancer? A Comparative analysis.
Rabkin Z; Israel O; Keidar Z
J Nucl Med; 2010 Jul; 51(7):1015-20. PubMed ID: 20554733
[TBL] [Abstract][Full Text] [Related]
15. Metabolic effect of pancreatoduodenectomy: Resolution of diabetes mellitus after surgery.
Kang MJ; Jung HS; Jang JY; Jung W; Chang J; Shin YC; Kim SW
Pancreatology; 2016; 16(2):272-7. PubMed ID: 26899541
[TBL] [Abstract][Full Text] [Related]
16. Increased serum levels of betatrophin in pancreatic cancer-associated diabetes.
Susanto H; Liu TY; Chen CC; Purnomo JD; Chen SF; Wang CH
Oncotarget; 2016 Jul; 7(27):42330-42339. PubMed ID: 27276680
[TBL] [Abstract][Full Text] [Related]
17. Resolution of new-onset diabetes after radical pancreatic resection predicts long-term survival in patients with pancreatic ductal cell adenocarcinoma.
He XY; Li JF; Yao WY; Yuan YZ
Ann Surg Oncol; 2013 Nov; 20(12):3809-16. PubMed ID: 23943021
[TBL] [Abstract][Full Text] [Related]
18. Risk factor, early diagnosis and overall survival on outcome of association between pancreatic cancer and diabetes mellitus: Changes and advances, a review.
Khadka R; Tian W; Hao X; Koirala R
Int J Surg; 2018 Apr; 52():342-346. PubMed ID: 29535016
[TBL] [Abstract][Full Text] [Related]
19. Resectability of presymptomatic pancreatic cancer and its relationship to onset of diabetes: a retrospective review of CT scans and fasting glucose values prior to diagnosis.
Pelaez-Luna M; Takahashi N; Fletcher JG; Chari ST
Am J Gastroenterol; 2007 Oct; 102(10):2157-63. PubMed ID: 17897335
[TBL] [Abstract][Full Text] [Related]
20. The relationship between new-onset diabetes mellitus and pancreatic cancer risk: a case-control study.
Ben Q; Cai Q; Li Z; Yuan Y; Ning X; Deng S; Wang K
Eur J Cancer; 2011 Jan; 47(2):248-54. PubMed ID: 20709528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
